Provided by Tiger Trade Technology Pte. Ltd.

SILO PHARMA INC.

1.46
-0.0420-2.80%
Post-market: 1.21-0.2479-17.00%19:59 EDT
Volume:1.15M
Turnover:1.74M
Market Cap:2.56M
PE:-0.29
High:1.57
Open:1.50
Low:1.45
Close:1.50
52wk High:10.87
52wk Low:1.45
Shares:1.75M
Float Shares:1.52M
Volume Ratio:17.81
T/O Rate:75.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0667
EPS(LYR):-7.5654
ROE:-91.23%
ROA:-44.25%
PB:0.52
PE(LYR):-0.19

Loading ...

Silo Pharma Enters Asset Purchase Agreement with Norsight Consulting on Oct 1 - SEC Filing

Reuters
·
16 hours ago

Silo Pharma - to Buy Software and Intellectual Property from Norsight Consulting - SEC Filing

THOMSON REUTERS
·
17 hours ago

Silo Pharma Issues Warrant for up to 300,000 Shares in Unregistered Sale Under Asset Purchase Deal

Reuters
·
17 hours ago

Silo Pharma Unit QwikAgents Adds Nvidia Nemotron Model Support

Reuters
·
Sep 30

Silo Pharma’s Qwikagents Expands AI Agent Platform with Nvidia Model Support and New Runtime Flexibility

THOMSON REUTERS
·
Sep 30

Silo Pharma Wins US Patent Allowance for SPC-15 PTSD Treatment Claims

Reuters
·
Sep 18

Silo Pharma Attends IPAC-RS Nasal Innovation Forum, Spotlights SPC-15 Nose-to-Brain PTSD Delivery Technology

Reuters
·
Sep 09

Silo Pharma - Enters Asset Purchase Agreement with Parkview Consulting on August 18, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 20

Silo Pharma Issues 165,000 Unregistered Shares in Asset Purchase Deal

Reuters
·
Aug 20

Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel Ptsd Treatment

THOMSON REUTERS
·
Aug 19

Silo Pharma Says Canada Issues Notice of Allowance for SPC-15 PTSD Patent Application

Reuters
·
Aug 19

Silo Pharma Shareholders Approved Authorized Common Share Increase at Annual Meeting

Reuters
·
Aug 18

Silo Pharma Q2 FY26 Net Loss Narrows 30.8% to $832,829

Reuters
·
Aug 14

Silo Pharma Wins European Patent for PTSD Prevention Therapy SPC-15

Reuters
·
Aug 10

Silo Pharma Granted European Patent Covering Novel Ptsd Therapy

THOMSON REUTERS
·
Aug 10

Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform

GlobeNewswire
·
Aug 06

Silo Pharma: Selling Shareholders Offer on Resale Basis 1.9 Mln Shares of Silo Pharma Common Stock - SEC Filing

THOMSON REUTERS
·
Jul 25

Silo Pharma subsidiary QwikAgents joins AMD AI program

TIPRANKS
·
Jul 14

Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform

GlobeNewswire
·
Jul 14

Top Midday Decliners

MT Newswires Live
·
Jul 11